The story of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its patent expiration created a deluge of generic competition , significantly eroding its dominance. While specific pharmaceutical companies may try to capitalize on male sexual dysfunct